We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
AUM
$783M
AUM Growth
+$436M
Cap. Flow
+$391M
Cap. Flow %
49.96%
Top 10 Hldgs %
43.72%
Holding
102
New
9
Increased
54
Reduced
8
Closed
4

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$37M
2
V icon
Visa
V
+$28.1M
3
AMZN icon
Amazon
AMZN
+$25.5M
4
GPN icon
Global Payments
GPN
+$20.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.1M

Sector Composition

Rank Sector Weight
1 Healthcare 24.92%
2 Technology 23.79%
3 Industrials 13.26%
4 Financials 9.64%
5 Consumer Discretionary 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DG icon
26
Dollar General
DG
$25.9B
$13.2M 1.68%
84,498
+75,885
+881% +$12M
GH icon
27
Guardant Health
GH
$19.5B
$11.2M 1.43%
143,184
+100,167
+233% +$7.22M
ADPT icon
28
Adaptive Biotechnologies
ADPT
$3.56B
$10.9M 1.39%
363,609
+313,150
+621% +$8.99M
BALL icon
29
Ball Corp
BALL
$17B
$10.8M 1.37%
166,464
+146,768
+745% +$9.95M
NXPI icon
30
NXP Semiconductors
NXPI
$68B
$9.99M 1.28%
+78,468
New +$9.11M
AYX
31
DELISTED
Alteryx Inc
AYX
$9.83M 1.26%
+98,228
New +$9.98M
AMT icon
32
American Tower
AMT
$77.7B
$9.19M 1.17%
40,000
BMY icon
33
Bristol-Myers Squibb
BMY
$127B
$7.82M 1%
+121,784
New +$6.97M
PH icon
34
Parker-Hannifin
PH
$125B
$6.78M 0.87%
32,931
-4
-0% -$775
PCH
35
DELISTED
PotlatchDeltic
PCH
$6.56M 0.84%
151,661
AAPL icon
36
Apple
AAPL
$4.89T
$6.37M 0.81%
86,748
+7,016
+9% +$451K
COO icon
37
Cooper Companies
COO
$13.7B
$5.14M 0.66%
64,000
MUSA icon
38
Murphy USA
MUSA
$11.3B
$5.08M 0.65%
43,413
SAGE
39
DELISTED
Sage Therapeutics
SAGE
$4.88M 0.62%
67,613
+53,603
+383% +$6.59M
BAC icon
40
Bank of America
BAC
$435B
$4.24M 0.54%
120,410
+40,995
+52% +$1.32M
BA icon
41
Boeing
BA
$165B
$3.83M 0.49%
11,742
+359
+3% +$127K
FIS icon
42
Fidelity National Information Services
FIS
$21.5B
$3.31M 0.42%
23,833
+1,521
+7% +$204K
EOG icon
43
EOG Resources
EOG
$78B
$3.28M 0.42%
39,179
+7,810
+25% +$572K
ABT icon
44
Abbott
ABT
$180B
$2.86M 0.37%
32,908
+3,892
+13% +$326K
NSC icon
45
Norfolk Southern
NSC
$78.8B
$2.24M 0.29%
11,558
+1,307
+13% +$245K
BDX icon
46
Becton Dickinson
BDX
$43.1B
$2.19M 0.28%
8,263
+857
+12% +$214K
IFF icon
47
International Flavors & Fragrances
IFF
$19.4B
$2.12M 0.27%
16,466
BMRN icon
48
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.11M 0.27%
25,000
AVGO icon
49
Broadcom
AVGO
$1.82T
$2.06M 0.26%
65,350
+7,650
+13% +$232K
TEL icon
50
TE Connectivity
TEL
$58.8B
$1.92M 0.24%
20,000

Similar funds

Aristotle Atlantic Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Aristotle Atlantic Partners held 102 positions worth $783M, up 126% from $347M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Aristotle Atlantic Partners deployed $391M of net new capital in Q4 2019, opening 9 new positions and adding to 54 existing holdings. Its largest new stake was Alteryx Inc: 98,228 shares worth $9.83M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Zions Bancorporation, an estimated $699K trimmed.

  • Aristotle Atlantic Partners's largest Q4 2019 buy was Alteryx Inc: 98,228 shares worth $9.83M.
  • Aristotle Atlantic Partners added most to Microsoft in Q4 2019, an estimated $37M increase.
  • Aristotle Atlantic Partners's biggest Q4 2019 reduction was Zions Bancorporation, cutting an estimated $699K.
  • Aristotle Atlantic Partners fully exited Celgene Corp in Q4 2019, selling an estimated $11.6M.
  • Aristotle Atlantic Partners's ten largest holdings make up 44% of its $783M portfolio in Q4 2019.
  • Aristotle Atlantic Partners opened 9 new positions and closed 4 in Q4 2019.
  • Aristotle Atlantic Partners's portfolio value rose 126% quarter-over-quarter to $783M.

Based on Aristotle Atlantic Partners's 13F filing for Q4 2019, filed 13 Feb 2020.